{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:31:09Z","timestamp":1794576669393,"version":"4.9.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-025-02172-3","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:26:02Z","timestamp":1761121562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Ergotamine, triptans, and the global challenge of medication-overuse headache: a call to action from Asia\u2013Oceania"],"prefix":"10.1186","volume":"26","author":[{"given":"Tissa","family":"Wijeratne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Martelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"2172_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12883-015-0422-1","volume":"15","author":"Z Yan","year":"2015","unstructured":"Yan Z et al (2015) Analysis of risk factors for medication-overuse headache relapse: a clinic-based study in China. BMC Neurol 15:168","journal-title":"BMC Neurol"},{"issue":"4","key":"2172_CR2","first-page":"e37985","volume":"15","author":"AS Alharbi","year":"2023","unstructured":"Alharbi AS et al (2023) Assessment of the prevalence and level of awareness of medication overuse headache among the general population in Makkah City, Saudi Arabia. Cureus 15(4):e37985","journal-title":"Cureus"},{"issue":"6","key":"2172_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0306264","volume":"19","author":"SC Bailey","year":"2024","unstructured":"Bailey SC et al (2024) Association between awareness and knowledge of medication-overuse headache with medication-taking behavior among adults with migraine. PLoS ONE 19(6):e0306264","journal-title":"PLoS ONE"},{"issue":"3","key":"2172_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000538528","volume":"17","author":"H Liu","year":"2024","unstructured":"Liu H et al (2024) Association between body mass index and Medication-Overuse headache among individuals with migraine: A Cross-Sectional study. Obes Facts 17(3):286\u2013295","journal-title":"Obes Facts"},{"issue":"3","key":"2172_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3988\/jcn.2016.12.3.316","volume":"12","author":"MJ Cha","year":"2016","unstructured":"Cha MJ (2016) Chronic daily headache and medication overuse headache in first-visit headache patients in Korea: a multicenter clinic-based study. J Clin Neurol 12(3):316\u2013322","journal-title":"J Clin Neurol"},{"key":"2172_CR6","unstructured":"Murphy C, Hameed S (2024) Chronic Headaches, in StatPearls. StatPearls Publishing Copyright \u00a9, StatPearls Publishing LLC.: Treasure Island (FL) ineligible companies. Disclosure: Sajid Hameed declares no relevant financial relationships with ineligible companies.\u00a02024 https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559083\/"},{"key":"2172_CR7","doi-asserted-by":"publisher","first-page":"647995","DOI":"10.3389\/fneur.2021.647995","volume":"12","author":"C Baraldi","year":"2021","unstructured":"Baraldi C et al (2021) Chronic migraine and medication overuse headache worsening after OnabotulinumtoxinA withdrawn due to the severe acute respiratory Syndrome-Coronavirus-2 pandemic. Front Neurol 12:647995","journal-title":"Front Neurol"},{"issue":"6","key":"2172_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10194-011-0388-3","volume":"12","author":"A Negro","year":"2011","unstructured":"Negro A, Martelletti P (2011) Chronic migraine plus medication overuse headache: two entities or not? J Headache Pain 12(6):593\u2013601","journal-title":"J Headache Pain"},{"key":"2172_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.654900","volume":"12","author":"G Mastria","year":"2021","unstructured":"Mastria G (2021) Chronic migraine preventive treatment by prefrontal-occipital transcranial direct current stimulation (tDCS): a proof-of-concept study on the effect of psychiatric comorbidities. Front Neurol 12:654900","journal-title":"Front Neurol"},{"key":"2172_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-015-0561-1","volume":"16","author":"B Shand","year":"2015","unstructured":"Shand B et al (2015) Clinical and demographical characteristics of patients with medication overuse headache in Argentina and chile: analysis of the Latin American section of COMOESTAS project. J Headache Pain 16:83","journal-title":"J Headache Pain"},{"issue":"2","key":"2172_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/0333102410373155","volume":"31","author":"AD Hershey","year":"2011","unstructured":"Hershey AD et al (2011) Genomic expression patterns in medication overuse headaches. Cephalalgia 31(2):161\u2013171","journal-title":"Cephalalgia"},{"issue":"11","key":"2172_CR12","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","volume":"17","author":"Global","year":"2018","unstructured":"Global (2018) regional, and National burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 17(11):954\u2013976","journal-title":"Lancet Neurol"},{"issue":"2","key":"2172_CR13","doi-asserted-by":"publisher","first-page":"E115","DOI":"10.36076\/ppj.2025.28.E115","volume":"28","author":"W Luo","year":"2025","unstructured":"Luo W (2025) Gray matter alterations in medication overuse headache: a voxel-based morphometry meta-analysis. Pain Physician 28(2):E115-e127","journal-title":"Pain Physician"},{"issue":"1","key":"2172_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01889-x","volume":"25","author":"A Raggi","year":"2024","unstructured":"Raggi A et al (2024) Hallmarks of primary headache: part 1 - migraine. J Headache Pain 25(1):189","journal-title":"J Headache Pain"},{"issue":"1","key":"2172_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2023-000418","volume":"5","author":"T Wijeratne","year":"2023","unstructured":"Wijeratne T (2023) Assessing and managing medication overuse headache in Australian clinical practice. BMJ Neurol Open 5(1):e000418","journal-title":"BMJ Neurol Open"},{"issue":"1","key":"2172_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01816-0","volume":"25","author":"T Wijeratne","year":"2024","unstructured":"Wijeratne T (2024) Unveiling a groundbreaking alliance: the inaugural collaboration between the Asian regional consortium of headache and the Journal of Headache and Pain. J Headache Pain 25(1):125","journal-title":"J Headache Pain"},{"issue":"4","key":"2172_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/14737167.2024.2321244","volume":"24","author":"A Raggi","year":"2024","unstructured":"Raggi A, Leonardi M, Martelletti P (2024) A proposal of actions for stakeholders and policy makers to address the global burden of headache disorders by 2030: why is this important for global health? Expert Rev Pharmacoecon Outcomes Res 24(4):459\u2013461","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"1","key":"2172_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01700-3","volume":"25","author":"M Leonardi","year":"2024","unstructured":"Leonardi M (2024) The world health organization intersectoral global action plan on epilepsy and other neurological disorders and the headache revolution: from headache burden to a global action plan for headache disorders. J Headache Pain 25(1):4","journal-title":"J Headache Pain"},{"key":"2172_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2025.2450647","author":"WD Wells-Gatnik","year":"2025","unstructured":"Wells-Gatnik WD, Martelletti P (2025) Therapeutic barriers for headache management: issues facing the global North and global South in 2024. Expert Rev Neurother. https:\/\/doi.org\/10.1080\/14737175.2025.2450647","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"2172_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01666-2","volume":"24","author":"P Martelletti","year":"2023","unstructured":"Martelletti P (2023) Rethinking headache as a global public health case model for reaching the SDG 3 health by 2030. J Headache Pain 24(1):140","journal-title":"J Headache Pain"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02172-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-025-02172-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02172-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:26:04Z","timestamp":1761121564000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-025-02172-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2172"],"URL":"https:\/\/doi.org\/10.1186\/s10194-025-02172-3","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"22 October 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Professor Tissa Wijeratne is Associate Editor of the Journal of Headache and Pain. Paolo Martelletti serves as the Editor-in-Chief of the Journal of Headache and Pain. The authors declare that they have no financial or non-financial competing interests relevant to this editorial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"228"}}